Funding supports a new investigator-initiated breast cancer clinical trial in Finland that takes on MYC oncogene. Cancer IO personnel played a major role in the upcoming clinical trial: Juha Klefström and Heidi Haikala were the investigators behind the pre-clinical findings, and Jeroen Pouwels was responsible for the biomarker study planning. Jane and Aatos Erkko Foundation […]

10 million € investment boosts Finnish capabilities in cancer immunotherapy Cancer IO is a new cancer immunotherapy focused top-level collaborative research and innovation project that starts as a part of the Business Finland’s Personalized Health Program. This University of Helsinki coordinated project integrates immuno-oncology (IO) activities at the Universities of Helsinki and Turku, 3 University

Cancer IO – New cancer immunotherapy collaboration project comes to life!Read More »